Evidence map›Paper›PMID 29853411›Full record

ReviewEpidemics2018

Modelling the global spread of diseases: A review of current practice and capability.

Caroline E Walters, Margaux M I Meslé, Ian M Hall

Abstract readReview
In one paragraph

Review in Epidemics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. SIRI+Q model with a limited capacity of isolation.Theory in biosciences = Theorie in den Biowissenschaften · 2025
    Article
  2. Modeling severe uncontrolled asthma: Transitioning away from health states.Contemporary clinical trials communications · 2024
    Article
  3. Article
  4. Article
  5. How to avoid a local epidemic becoming a global pandemic.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Can infectious modelling be applicable globally - lessons from COVID 19.Current opinion in environmental science & health · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Monitoring COVID-19 contagion growth.Statistics in medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Caroline E WaltersEmergency Response Department Science and Technology, Public Health England, Porton Down, UK. Electronic address: c.walters@imperial.ac.uk.
Margaux M I MesléNIHR, Health Protection Research Unit in Emerging and Zoonotic Infections at University of Liverpool, Liverpool, UK; Institute of Infection and Global Health, The University of Liverpool, Liverpool, UK.
Ian M HallEmergency Response Department Science and Technology, Public Health England, Porton Down, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mathematical models can aid in the understanding of the risks associated with the global spread of infectious diseases. To assess the current state of mathematical models for the global spread of infectious diseases, we reviewed the literature highlighting common approaches and good practice, and identifying research gaps. We followed a scoping study method and extracted information from 78 records on: modelling approaches; input data (epidemiological, population, and travel) for model parameterization; model validation data. We found that most epidemiological data come from published journal articles, population data come from a wide range of sources, and travel data mainly come from statistics or surveys, or commercial datasets. The use of commercial datasets may benefit the modeller, however makes critical appraisal of their model by other researchers more difficult. We found a minority of records (26) validated their model. We posit that this may be a result of pandemics, or far-reaching epidemics, being relatively rare events compared with other modelled physical phenomena (e.g. climate change). The sparsity of such events, and changes in outbreak recording, may make identifying suitable validation data difficult. We appreciate the challenge of modelling emerging infections given the lack of data for both model parameterisation and validation, and inherent complexity of the approaches used. However, we believe that open access datasets should be used wherever possible to aid model reproducibility and transparency. Further, modellers should validate their models where possible, or explicitly state why validation was not possible.

Indexed as

Models, TheoreticalCommunicable DiseasesDisease OutbreaksHumansReproducibility of ResultsTravelDisease spreadInfluenzaMathematical modellingScoping review

Identifiers

PMID29853411
PMCPMC6227252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.